Limula News and Resources

Limula has raised CHF6.2M ($6.8M) to advance its automated cell therapy manufacturing platform, aiming to make life-saving therapies more accessible. The oversubscribed seed round was led by LifeX Ventures, with contributions from multiple investors. Founded in 2020, Limula is addressing